ChromaTan, Inc. Selected as a BLUE KNIGHT™ Company
November 21, 2023
LOWER GWYNEDD, Penn. -- ChromaTan, Inc., a bioprocess development company revolutionizing the 123-year-old traditional batch biopurification process through transformational next-generation biomanufacturing solutions, announced today that it has been selected as a BLUE KNIGHT™ company. Blue Knight is a joint initiative between Johnson & Johnson Innovation - JLABS (JLABS) and the Biomedical Advanced Research and Development Authority [...]
Element Biosciences Welcomes William P. Donnelly to its Board of Directors
November 21, 2023
SAN DIEGO, CA – Element Biosciences, Inc., developer of the Element AVITI™ System, an innovative DNA sequencing platform that is disrupting the genomics industry, announced that William (Bill) P. Donnelly has joined its board of directors. Mr. Donnelly spent more than 20 years growing the international instrumentation firm Mettler-Toledo International Inc. and currently serves as lead independent director [...]
BD Names Dr. Ronald Silverman as Chief Medical Officer
November 21, 2023
FRANKLIN LAKES, N.J. -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that Ronald (Ron) Silverman, MD, FACS, has been named executive vice president and chief medical officer of BD, effective Dec. 4, 2023. Dr. Silverman will be responsible for leading the company's Medical Affairs organization, which includes end-to-end medical [...]
MantiSpectra Secures €4 Million in seed investment funding
November 21, 2023
The Eindhoven-based deep-tech company MantiSpectra, a Spinoff of the Eindhoven University of Technology, has successfully secured €4 million funding to support its mission to revolutionize how we ‘see’ the world around us by enabling the adoption of near-infrared spectroscopy everywhere. Innovation Industries and PhotonVentures led the funding round. Together with the support from the PhotonDelta National Growth Fund programme, this [...]
Goldcup 34064 AB Announces Vironova BioAnalytics Acquired by Investor Group
November 20, 2023
Vironova BioAnalytics AB Acquired by an investor syndicate, led by Quatre Lab, to expand its TEM services for the pharmaceutical industry; to be rebranded as QuTEM STOCKHOLM, SWEDEN -- Vironova BioAnalytics, a leading provider of transmission electron microscopy (TEM) services, is pleased to announce its acquisition led by QuatreLab (a quality control company created by [...]
November 20, 2023
Sapio’s responsive, expert customer support team rapidly configured the platform to optimize and accelerate ImmuneBridge’s unique research ImmuneBridge, a developer of allogeneic, off-the-shelf cellular immunotherapies, has launched a new electronic lab notebook (ELN) from Sapio Sciences, LLC. The new ELN provides a unified, no-code platform for data management and experiment tracking, enabling ImmuneBridge to modernize, adapt, and scale its [...]
November 20, 2023
The LightCycler PRO System is designed to be the most advanced qPCR technology for both clinical diagnostics and research The new system will advance personalised healthcare and support outbreak readiness by delivering agility and flexibility for translational research and diagnostics The innovative features of the system utilises gold standard technology for quality, precision and reliability [...]
The Institute of Human Genetics, Polish Academy of Sciences (IHG PAS) is Live on SOPHiA GENETICS
November 20, 2023
The SOPHiA DDM™ Platform used by IHG PAS to advance its research of male infertility BOSTON and Rolle, Switzerland – SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced that the Institute of Human Genetics, Polish Academy of Sciences (IHG PAS), the leading center for genetics research in Poland, [...]
November 20, 2023
Yourgene’s LightBench® instrument offers precise and accurate size selection of PacBio® SMRTbell® sequencing libraries increasing HiFi sequencing yields Manchester, UK: Yourgene Health (part of the Novacyt group of companies), a leading international molecular diagnostics group, and PacBio, a leading developer of high-quality, highly accurate sequencing solutions, today announced a collaboration to optimise size selection for [...]
InSphero Enables Novel Drug Discovery in Liver Disease by Launching the MASH CALL Initiative
November 20, 2023
InSphero AG, the global leader in 3D in vitro technologies for drug discovery, announces the launch of the MASH CALL Initiative for fast and reliable identification and comparison of therapeutic candidates for the clinical treatment of MASH. Zurich, Switzerland -- InSphero AG, the global leader in 3D cell culture technologies for drug discovery, announces the launch of the MASH [...]

